Skip to content

Medication Review in Women With Depression and Anxiety

Assessing the Impact of Medication Management Review Service for Females Diagnosed With Depression and Anxiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04082871
Enrollment
73
Registered
2019-09-09
Start date
2016-08-01
Completion date
2017-01-10
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adherence, Patient, Depression, Anxiety

Keywords

Medication management review service, Pharmaceutical care, Clinical pharmacist

Brief summary

This study sought to assess the impact of the MMR service on identifying and resolving TRPs, improving adherence, depression and anxiety scores in females diagnosed with depression and anxiety in Jordan

Detailed description

Participants were recruited into this single-blind parallel randomized controlled trial and randomized into active and control groups. A clinical pharmacist identified TRPs for all participants. Adherence, depression and anxiety scores were assessed. Active group patients received the MMR service: pharmacist-delivered counseling and a letter with recommended changes in the patient's treatment plan was sent to the patient's psychiatrist to be applied. Control group participants did not receive the intervention. Follow-up assessments were completed for all patients at 3 months from baseline. Main outcome measures were TRPs, adherence, depression and anxiety scores.

Interventions

OTHERMedication management review

The researcher screened each completed an MMR template and verified that all information in each patient template was complete. A classification system was then used to identify the TRPs which either actually or potentially interfered with the clinical outcomes for each patient.\[19\] This system was explained in detail and applied successfully in many previous studies.\[10, 14, 20\] The researcher then identified TRPs for each patient in both groups using evidence-based medicine. The TRPs including unneeded drug treatment, untreated condition/s, efficacy/effectiveness issues, safety issues, inadequate knowledge, inappropriate adherence to pharmacological therapy, inappropriate adherence to self-care activities and miscellaneous problems.

Sponsors

Applied Science Private University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

This single-blind parallel randomized controlled trial

Intervention model description

Following recruitment, participants were randomized into two groups (1:1 randomization), active and control, using the computer-generated randomization program (www.randomization.com). The researcher generated the allocation sequence, and assigned the participants to their group. Participant who came into the clinic during the clinic's working hours (Sunday to Thursday, from 9 am to 1 pm) were approached consecutively and allocated to the active or control group. Participants were not aware of which study group they were assigned to; only the researcher was aware of each patient's group assignment. Participants in the active and control groups completed a baseline and follow-up (3 months from baseline) visits at the same outpatient psychiatric clinic with the researcher conducting the interview using the study tool to complete the MMR process.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Jordanian females or residents in Jordan for the last 12 months and planning to stay in Jordan for 6 months (the study follow-up period), * above the age of 18 years * diagnosed with depression and/or anxiety for at least 4 weeks duration * taking medications for depression and/or anxiety

Exclusion criteria

* presence of a cognitive problem or sensory impairment which may prevent communication with the patient (reported by the patient's psychiatrist) * being not able to speak or write Arabic (reported by the patient)

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the effect of the medication management review service delivered to females living in Jordan and diagnosed with depression and anxiety6 monthsthe medication management review service will be measured by the reduction of treatment related number after providing the service

Secondary

MeasureTime frameDescription
Patient's satisfaction with the medication management review service6 monthssatisfaction will be measured by the willingness of patients to pay for the provided services

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026